<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34721055</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-042X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in physiology</Title><ISOAbbreviation>Front Physiol</ISOAbbreviation></Journal><ArticleTitle>Diabetes, Heart Failure, and COVID-19: An Update.</ArticleTitle><Pagination><StartPage>706185</StartPage><MedlinePgn>706185</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">706185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2021.706185</ELocationID><Abstract><AbstractText>The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the WHO in March 2020. As of August 2021, more than 220 countries have been affected, accounting for 211,844,613 confirmed cases and 4,432,802 deaths worldwide. A new delta variant wave is sweeping through the globe. While previous reports consistently have demonstrated worse prognoses for patients with existing cardiovascular disease than for those without, new studies are showing a possible link between SARS-CoV-2 infection and an increased incidence of new-onset heart disease and diabetes, regardless of disease severity. If this trend is true, with hundreds of millions infected, the disease burden could portend a potentially troubling increase in heart disease and diabetes in the future. Focusing on heart failure in this review, we discuss the current data at the intersection of COVID, heart failure, and diabetes, from clinical findings to potential mechanisms of how SARS-CoV-2 infection could increase the incidence of those pathologies. Additionally, we posit questions for future research areas regarding the significance for patient care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Hebbard, Lee, Katare and Garikipati.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hebbard</LastName><ForeName>Carleigh</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Brooke</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katare</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology-HeartOtago, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garikipati</LastName><ForeName>Venkata Naga Srikanth</ForeName><Initials>VNS</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Physiol</MedlineTA><NlmUniqueID>101549006</NlmUniqueID><ISSNLinking>1664-042X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CVD (cardio vascular disease)</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">diabetic cardio</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>1</Day><Hour>9</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34721055</ArticleId><ArticleId IdType="pmc">PMC8554151</ArticleId><ArticleId IdType="doi">10.3389/fphys.2021.706185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe T., Egbuche O., Igwe J., Jegede O., Wagle B., Olanipekun T., et al. (2021). Cardiovascular complications in COVID-19 patients with or without diabetes mellitus. Endocrinol. Diab. Metab. 4:e00218. 10.1002/edm2.218</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/edm2.218</ArticleId><ArticleId IdType="pmc">PMC7883043</ArticleId><ArticleId IdType="pubmed">33614986</ArticleId></ArticleIdList></Reference><Reference><Citation>Accili D. (2021). Can COVID-19 cause diabetes? Nat. Metab. 3 123&#x2013;125. 10.1038/s42255-020-00339-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00339-7</ArticleId><ArticleId IdType="pmc">PMC8892570</ArticleId><ArticleId IdType="pubmed">33432203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D., Halpin S., Lewthwaite P., Salawu A., et al. (2020). Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J. Rehabil. Med. 52:jrm00063. 10.2340/16501977-2694</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594 259&#x2013;264. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J., Lee S., Gupta A., Cagliostro M., Joshi A. A., Rivas-Lasarte M., et al. (2020). Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J. Am. Coll. Cardiol. 76 2334&#x2013;2348. 10.1016/j.jacc.2020.09.549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.09.549</ArticleId><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Argulian E., Sud K., Vogel B., Bohra C., Garg V. P., Talebi S., et al. (2020). Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC: Cardiovasc. Imag. 13 2459&#x2013;2461. 10.1016/j.jcmg.2020.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7228729</ArticleId><ArticleId IdType="pubmed">32426088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J., Shi J., Cao J., Wen H., Wang F., Mubarik S., et al. (2020). The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China. Glob. Health Res. Policy 5:54. 10.1186/s41256-020-00183-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41256-020-00183-y</ArticleId><ArticleId IdType="pmc">PMC7750392</ArticleId><ArticleId IdType="pubmed">33349271</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron E., Bakhai C., Kar P., Weaver A., Bradley D., Ismail H., et al. (2020). Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diab. Endocrinol. 8 813&#x2013;822. 10.1016/S2213-8587(20)30272-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30272-2</ArticleId><ArticleId IdType="pmc">PMC7426088</ArticleId><ArticleId IdType="pubmed">32798472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt A. S., Jering K. S., Vaduganathan M., Claggett B. L., Cunningham J. W., Rosenthal N., et al. (2021). Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 9 65&#x2013;73. 10.1016/j.jchf.2020.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7833294</ArticleId><ArticleId IdType="pubmed">33384064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode B., Garrett V., Messler J., McFarland R., Crowe J., Booth R., et al. (2020). Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the united states. J. Diab. Sci. Technol. 14 813&#x2013;821. 10.1177/1932296820924469</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296820924469</ArticleId><ArticleId IdType="pmc">PMC7673150</ArticleId><ArticleId IdType="pubmed">32389027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S. R., Rubino F., Khunti K., Mingrone G., Hopkins D., Birkenfeld A. L., et al. (2020). Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diab. Endocrinol. 8 546&#x2013;550. 10.1016/S2213-8587(20)30152-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30152-2</ArticleId><ArticleId IdType="pmc">PMC7180013</ArticleId><ArticleId IdType="pubmed">32334646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Coats A. J. S., Tsutsui H., Abdelhamid C. M., Adamopoulos S., Albert N., et al. (2021). Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur. J. Heart Fail. 23 352&#x2013;380. 10.1002/ejhf.2115</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2115</ArticleId><ArticleId IdType="pubmed">33605000</ArticleId></ArticleIdList></Reference><Reference><Citation>Brufsky A. (2020). Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J. Med. Virol. 92 770&#x2013;775. 10.1002/jmv.25887</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25887</ArticleId><ArticleId IdType="pmc">PMC7262330</ArticleId><ArticleId IdType="pubmed">32293710</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M., Zhang D., Wang Y., Lu Y., Zhu X., Li Y., et al. (2020). Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. medRXiv 1&#x2013;30. [preprint]. 10.1101/2020.03.04.20030395</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.04.20030395</ArticleId><ArticleId IdType="pmc">PMC7255784</ArticleId><ArticleId IdType="pubmed">32511465</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G., Larcher A., Tomelleri A., Campochiaro C., Della-Torre E., De Luca G., et al. (2021). Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 3 e253&#x2013;e261. 10.1016/S2665-9913(21)00012-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00012-6</ArticleId><ArticleId IdType="pmc">PMC7906668</ArticleId><ArticleId IdType="pubmed">33655218</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Perlman S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39 529&#x2013;539. 10.1007/s00281-017-0629-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappel M. C., Ferrario C. M. (2006). ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1&#x2013;7). Kidney Int. 70 8&#x2013;10. 10.1038/sj.ki.5000321</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000321</ArticleId><ArticleId IdType="pubmed">16810285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasouraki A. M., Violetis O. A., Abdelrasoul M., Tsagalou E. P. (2020). Acute myocarditis related to COVID-19: comparison to SARS and MERS. SN Compr. Clin. Med. 2 2684&#x2013;2690. 10.1007/s42399-020-00563-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00563-y</ArticleId><ArticleId IdType="pmc">PMC7677600</ArticleId><ArticleId IdType="pubmed">33235977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatrath N., Kaza N., Pabari P. A., Fox K., Mayet J., Barton C., et al. (2020). The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure. ESC Heart Fail. 7 4443&#x2013;4447. 10.1002/ehf2.13059</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13059</ArticleId><ArticleId IdType="pmc">PMC7675415</ArticleId><ArticleId IdType="pubmed">33040480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Jiang Q., Xia X., Liu K., Yu Z., Tao W., et al. (2020). Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell 19:e13168. 10.1111/acel.13168</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13168</ArticleId><ArticleId IdType="pmc">PMC7323071</ArticleId><ArticleId IdType="pubmed">32558150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Fan Y., Wu X., Zhang L., Guo T., Deng K., et al. (2020). Clinical characteristics and Risk Factors for Fatal Outcome in Patients With 2019-Coronavirus Infected Disease (COVID-19) in Wuhan, China (2/27/2020). 10.2139/ssrn.3546069</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3546069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zheng F., Qing Y., Ding S., Yang D., Lei C., et al. (2020). Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study. medRXiv 1&#x2013;31. [preprint]. 10.1101/2020.03.03.20030353</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.03.20030353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra K. H., Chodavarapu H., Lazartigues E. (2013). Angiotensin converting enzyme 2: a new important player in the regulation of glycemia. IUBMB Life 65 731&#x2013;738. 10.1002/iub.1190</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1190</ArticleId><ArticleId IdType="pmc">PMC4557790</ArticleId><ArticleId IdType="pubmed">23893738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P. Y., Chui P., Ling A. E., Franks T. J., Tai D. Y. H., Leo Y. S., et al. (2004). Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch. Pathol. Lab. Med. 128 195&#x2013;204. 10.5858/2004-128-195-AODDTS</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2004-128-195-AODDTS</ArticleId><ArticleId IdType="pubmed">14736283</ArticleId></ArticleIdList></Reference><Reference><Citation>Coate K. C., Cha J., Shrestha S., Wang W., Gon&#xe7;alves L. M., Alma&#xe7;a J., et al. (2020). SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in &#x3b2; cells. Cell Metab. 32 1028.e1024&#x2013;1040.e1024. 10.1016/j.cmet.2020.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7664344</ArticleId><ArticleId IdType="pubmed">33207245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan N., Barda N., Kepten E., Miron O., Perchik S., Katz M. A., et al. (2021). BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med. 84 1412&#x2013;1423. 10.1056/NEJMoa2101765</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2101765</ArticleId><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M., Ferreira Ferranti J., de Almeida Monteiro R. A., Duarte-Neto A. N., Soares Gomes-Gouv&#xea;a M., Viu Degaspare N., et al. (2020). SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolescent Health 4 790&#x2013;794. 10.1016/S2352-4642(20)30257-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30257-1</ArticleId><ArticleId IdType="pmc">PMC7440866</ArticleId><ArticleId IdType="pubmed">32828177</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E., Du H., Gardner L. (2020). An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20 533&#x2013;534. 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Echouffo-Tcheugui J. B., Xu H., DeVore A. D., Schulte P. J., Butler J., Yancy C. W., et al. (2016). Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from get with the guidelines&#x2013;heart failure registry. Am. Heart J. 182 9&#x2013;20. 10.1016/j.ahj.2016.07.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2016.07.025</ArticleId><ArticleId IdType="pubmed">27914505</ArticleId></ArticleIdList></Reference><Reference><Citation>Einarson T. R., Acs A., Ludwig C., Panton U. H. (2018). Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007&#x2013;2017. Cardiovasc. Diabetol. 17:83. 10.1186/s12933-018-0728-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-018-0728-6</ArticleId><ArticleId IdType="pmc">PMC5994068</ArticleId><ArticleId IdType="pubmed">29884191</ArticleId></ArticleIdList></Reference><Reference><Citation>Eketunde A. O., Mellacheruvu S. P., Oreoluwa P. (2020). A review of postmortem findings in patients With COVID-19. Cureus 12:e9438. 10.7759/cureus.9438</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.9438</ArticleId><ArticleId IdType="pmc">PMC7451084</ArticleId><ArticleId IdType="pubmed">32864262</ArticleId></ArticleIdList></Reference><Reference><Citation>Freaney P. M., Shah S. J., Khan S. S. (2020). COVID-19 and heart failure with preserved ejection fraction. JAMA 324 1499&#x2013;1500. 10.1001/jama.2020.17445</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17445</ArticleId><ArticleId IdType="pubmed">33001179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheorghiade M., Pang P. S., O&#x2019;Connor C. M., Prasad K., McMurray J., Teerlink J. R., et al. (2011). Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am. Heart J. 161 224&#x2013;232. 10.1016/j.ahj.2010.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2010.10.023</ArticleId><ArticleId IdType="pubmed">21315202</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjesdal O., Bluemke D. A., Lima J. A. (2011). Cardiac remodeling at the population level&#x2014;risk factors, screening, and outcomes. Nat. Rev. Cardiol. 8 673&#x2013;685. 10.1038/nrcardio.2011.154</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2011.154</ArticleId><ArticleId IdType="pubmed">22027657</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziani D., Soriano J. B., Del Rio-Bermudez C., Morena D., D&#xed;az T., Castillo M., et al. (2020). Characteristics and prognosis of COVID-19 in patients with COPD. J. Clin. Med. 9:3259. 10.3390/jcm9103259</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9103259</ArticleId><ArticleId IdType="pmc">PMC7600734</ArticleId><ArticleId IdType="pubmed">33053774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gritte R. B., Souza-Siqueira T., Curi R., Machado M. C. C., Soriano F. G. (2021). Why septic patients remain sick after hospital discharge? Front. Immunol. 11:605666. 10.3389/fimmu.2020.605666</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.605666</ArticleId><ArticleId IdType="pmc">PMC7917203</ArticleId><ArticleId IdType="pubmed">33658992</ArticleId></ArticleIdList></Reference><Reference><Citation>Group R. C., Horby P., Lim W. S., Emberson J. R., Mafham M., Bell J. L., et al. (2021). Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384 693&#x2013;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., Liang W.-H., Ou C.-Q., He J.-X., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382 1708&#x2013;1720. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Guariguata L., Whiting D. R., Hambleton I., Beagley J., Linnenkamp U., Shaw J. E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diab. Res. Clin. Practice 103 137&#x2013;149. 10.1016/j.diabres.2013.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2013.11.002</ArticleId><ArticleId IdType="pubmed">24630390</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M. V., Sehgal K., Nair N., Mahajan S., Sehrawat T. S., et al. (2020). Extrapulmonary manifestations of COVID-19. Nat. Med. 26 1017&#x2013;1032. 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., et al. (2020). Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369 718&#x2013;724. 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann-Boyce J., Morris E., Goyder C., Kinton J., Perring J., Nunan D., et al. (2020). Diabetes and COVID-19: risks, management, and learnings from other national disasters. Dia Care 43 1695&#x2013;1703. 10.2337/dc20-1192</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1192</ArticleId><ArticleId IdType="pubmed">32546593</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P. A., Albert N. M., Allen L. A., Bluemke D. A., Butler J., Fonarow G. C., et al. (2013). Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ. Heart Fail. 6 606&#x2013;619. 10.1161/HHF.0b013e318291329a</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HHF.0b013e318291329a</ArticleId><ArticleId IdType="pmc">PMC3908895</ArticleId><ArticleId IdType="pubmed">23616602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermine O., Mariette X., Tharaux P.-L., Resche-Rigon M., Porcher R., Ravaud P., et al. (2021). Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern. Med. 181:32. 10.1001/jamainternmed.2020.6820</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6820</ArticleId><ArticleId IdType="pmc">PMC7577198</ArticleId><ArticleId IdType="pubmed">33080017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., M&#xe9;ar L., Edvinsson A., Micke P., Uhl&#xe9;n M., Lindskog C. (2020). The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16:e9610. 10.15252/msb.20209610</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 271.ee278&#x2013;280.ee278. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojyo S., Uchida M., Tanaka K., Hasebe R., Tanaka Y., Murakami M., et al. (2020). How COVID-19 induces cytokine storm with high mortality. Inflamm. Regener. 40:37. 10.1186/s41232-020-00146-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-020-00146-3</ArticleId><ArticleId IdType="pmc">PMC7527296</ArticleId><ArticleId IdType="pubmed">33014208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y., Huang J., Chen D., Ye Y., Su F., Dai J., et al. (2020). Clinical characteristics of Coronavirus Disease 2019 outside Wuhan and development of early risk stratification tool. Res. Sq. 1&#x2013;14. [preprint]. 10.21203/rs.3.rs-19481/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-19481/v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D. S. (2005). Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 60 401&#x2013;409. 10.1136/thx.2004.030205</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel W. B. (1979). Diabetes and cardiovascular disease. The Framingham study. JAMA: J. Am. Med. Assoc. 241 2035&#x2013;2038. 10.1001/jama.1979.03290450033020</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1979.03290450033020</ArticleId><ArticleId IdType="pubmed">430798</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R., Sharma B. R., Tuladhar S., Williams E. P., Zalduondo L., Samir P., et al. (2021). Synergism of TNF-&#x3b1; and IFN-&#x3b3; triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184 149.ee117&#x2013;168.ee117. 10.1016/j.cell.2020.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Korytkowski M., Antinori-Lent K., Drincic A., Hirsch I. B., McDonnell M. E., Rushakoff R., et al. (2020). A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic. J. Clin. Endocrinol. Metab. 105 3076&#x2013;3087. 10.1210/clinem/dgaa342</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa342</ArticleId><ArticleId IdType="pmc">PMC7313952</ArticleId><ArticleId IdType="pubmed">32498085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., et al. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus&#x2013;induced lung injury. Nat. Med. 11 875&#x2013;879. 10.1038/nm1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. S., Park S., Jeong H. W., Ahn J. Y., Choi S. J., Lee H., et al. (2020). Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5:eabd1554. 10.1126/sciimmunol.abd1554</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd1554</ArticleId><ArticleId IdType="pmc">PMC7402635</ArticleId><ArticleId IdType="pubmed">32651212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee L. Y., Cazier J. B., Angelis V., Arnold R., Bisht V., Campton N. A., et al. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 395 1919&#x2013;1926. 10.1016/S0140-6736(20)31173-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31173-9</ArticleId><ArticleId IdType="pmc">PMC7255715</ArticleId><ArticleId IdType="pubmed">32473682</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D. P., Nair G., Li W., Maric D., Murray H., et al. (2020). Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 384 481&#x2013;483. 10.1056/NEJMc2033369</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew J. K. S., Pearson J. T., Schwenke D. O., Katare R. (2017). Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways. Cardiovasc. Diabetol. 16:10. 10.1186/s12933-016-0484-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0484-4</ArticleId><ArticleId IdType="pmc">PMC5237289</ArticleId><ArticleId IdType="pubmed">28086863</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., et al. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 109 531&#x2013;538. 10.1007/s00392-020-01626-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Zuo X., Zhang H., Deng A. (2020). COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 22 1935&#x2013;1941. 10.1111/dom.14057</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14057</ArticleId><ArticleId IdType="pmc">PMC7264681</ArticleId><ArticleId IdType="pubmed">32314455</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Guan B., Su T., Liu W., Chen M., Bin Waleed K., et al. (2020). Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart 106:1142. 10.1136/heartjnl-2020-317062</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317062</ArticleId><ArticleId IdType="pmc">PMC7295861</ArticleId><ArticleId IdType="pubmed">32461330</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3 237&#x2013;261. 10.1146/annurev-virology-110615-042301</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S. S.-L., Cheng C.-W., Fu C.-L., Chan Y.-H., Lee M.-P., Chan J. W.-M., et al. (2003). Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation 108 1798&#x2013;1803. 10.1161/01.CIR.0000094737.21775.32</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000094737.21775.32</ArticleId><ArticleId IdType="pubmed">14504188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Bae J. H., Kwon H.-S., Nauck M. A. (2021). COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 17 11&#x2013;30. 10.1038/s41574-020-00435-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D., Fitzek A., Br&#xe4;uninger H., Aleshcheva G., Edler C., Meissner K., et al. (2020). Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 5:1281. 10.1001/jamacardio.2020.3551</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P. P., Blet A., Smyth D., Li H. (2020). The science underlying COVID-19: implications for the cardiovascular system. Circulation 142 68&#x2013;78. 10.1161/CIRCULATIONAHA.120.047549</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Luo H., Wang Y., Wang D., Ju S., Yang Y. (2020). Characteristics and Associations With Severity in COVID-19 Patients: A Multicentre Cohort Study From Jiangsu Province, China (2/28/2020). 10.2139/ssrn.3548753</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3548753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 565&#x2013;574. 10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Zhu X., Jian J., Chen X. U., Yin K. (2021). Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim. Biophys. Sin. (Shanghai) 53 273&#x2013;282. 10.1093/abbs/gmaa176</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmaa176</ArticleId><ArticleId IdType="pmc">PMC7929476</ArticleId><ArticleId IdType="pubmed">33428706</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S. D., Vardeny O. (2020). Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 5 831&#x2013;840. 10.1001/jamacardio.2020.1286</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1286</ArticleId><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwick T. H. (2008). Diabetic heart disease. Postgraduate Med. J. 84 188&#x2013;192. 10.1136/hrt.2005.067231</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2005.067231</ArticleId><ArticleId IdType="pubmed">18424575</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. (2020). Long-Haul COVID. Neurology 95 559&#x2013;560. 10.1212/WNL.0000000000010640</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G. Y., Kassiri Z., Jiang C., Liu P. P., Poutanen S. M., Penninger J. M., et al. (2009). SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Investigat. 39 618&#x2013;625. 10.1111/j.1365-2362.2009.02153.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153.x</ArticleId><ArticleId IdType="pmc">PMC7163766</ArticleId><ArticleId IdType="pubmed">19453650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozono S., Zhang Y., Ode H., Sano K., Tan T. S., Imai K., et al. (2021). SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat. Commun. 12:848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870668</ArticleId><ArticleId IdType="pubmed">33558493</ArticleId></ArticleIdList></Reference><Reference><Citation>Panhwar M. S., Kalra A., Gupta T., Kolte D., Khera S., Bhatt D. L., et al. (2019). Effect of influenza on outcomes in patients with heart failure. JACC Heart Fail. 7 112&#x2013;117. 10.1016/j.jchf.2018.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2018.10.011</ArticleId><ArticleId IdType="pubmed">30611718</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr J. B. (2021). Time to reassess Tocilizumab&#x2019;s role in COVID-19 Pneumonia. JAMA Intern. Med. 181:12. 10.1001/jamainternmed.2020.6557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6557</ArticleId><ArticleId IdType="pubmed">33079980</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris J., Chu C., Cheng V., Chan K., Hung I., Poon L., et al. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 1767&#x2013;1772. 10.1016/S0140-6736(03)13412-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13412-5</ArticleId><ArticleId IdType="pmc">PMC7112410</ArticleId><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Bermejo J. A., Kang S., Rockwood S. J., Simoneau C. R., Joy D. A., Ramadoss G. N., et al. (2020). SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. bioRxiv [Preprint] 10.1101/2020.08.25.265561</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.25.265561</ArticleId><ArticleId IdType="pmc">PMC8128284</ArticleId><ArticleId IdType="pubmed">33723017</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C. M., Jones S. A., Yang J., Rajagopalan H., O&#x2019;Donnell L., Chernyak Y., et al. (2020). Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRXiv 1&#x2013;25. [preprint]. 10.1101/2020.04.08.20057794</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.08.20057794</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. (2020). COVID-19, SARS and MERS: are they closely related? Clin. Microbiol. Infect. 26 729&#x2013;734. 10.1016/j.cmi.2020.03.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.03.026</ArticleId><ArticleId IdType="pmc">PMC7176926</ArticleId><ArticleId IdType="pubmed">32234451</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott H. C., Girard T. D. (2020). Recovery from severe COVID-19: leveraging the lessons of survival from sepsis. JAMA 324:739. 10.1001/jama.2020.14103</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.14103</ArticleId><ArticleId IdType="pubmed">32777028</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V. O., Carerj M. L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5:1265. 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi D., Yan X., Tang X., Peng J., Yu Q.1, Feng L., et al. (2020). Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study. medRXiv 1&#x2013;30. [preprint]. 10.1101/2020.03.01.20029397</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.01.20029397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S., Tong M. S., Borchers J., Zareba K. M., Obarski T. P., Simonetti O. P., et al. (2020). Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 6 116&#x2013;118. 10.1001/jamacardio.2020.4916</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D., Guasti L., Koehler F., Squizzato A., Nistri S., Christodorescu R., et al. (2021). Late Phase of COVID-19 pandemic in general cardiology. A position paper of the esc council for cardiology practice. ESC Heart Fail. 10.1002/ehf2.13466</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13466</ArticleId><ArticleId IdType="pmc">PMC8427022</ArticleId><ArticleId IdType="pubmed">34170086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V. A., Churilov L. P., Shoenfeld Y. (2021). Influenza infection, SARS, MERS and COVID-19: cytokine storm &#x2013; The common denominator and the lessons to be learned. Clin. Immunol. 223:108652. 10.1016/j.clim.2020.108652</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108652</ArticleId><ArticleId IdType="pmc">PMC7832378</ArticleId><ArticleId IdType="pubmed">33333256</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvarani C., Dolci G., Massari M., Merlo D. F., Cavuto S., Savoldi L., et al. (2021). Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized With COVID-19 Pneumonia: a randomized clinical trial. JAMA Intern. Med. 181:24. 10.1001/jamainternmed.2020.6615</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6615</ArticleId><ArticleId IdType="pmc">PMC7577199</ArticleId><ArticleId IdType="pubmed">33080005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., et al. (2020). Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 117 11727&#x2013;11734. 10.1073/pnas.2003138117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., et al. (2020). Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5:802. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H. K., Mehra M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J. Heart Lung Transplant. : Off. Publication Int. Soc. Heart Transplant. 39 405&#x2013;407. 10.1016/j.healun.2020.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2020.03.012</ArticleId><ArticleId IdType="pmc">PMC7118652</ArticleId><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., Goubet A.-G., Dubuisson A., Derosa L., et al. (2020). Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182 1401.e1418&#x2013;1418.e1418. 10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Solerte S. B., D&#x2019;Addio F., Trevisan R., Lovati E., Rossi A., Pastore I., et al. (2020). Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with Type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Dia Care 43 2999&#x2013;3006. 10.2337/dc20-1521</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1521</ArticleId><ArticleId IdType="pmc">PMC7770266</ArticleId><ArticleId IdType="pubmed">32994187</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon S. D., Rizkala A. R., Lefkowitz M. P., Shi V. C., Gong J., Anavekar N., et al. (2018). Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circ. Heart Fail. 11:e004962. 10.1161/CIRCHEARTFAILURE.118.004962</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.118.004962</ArticleId><ArticleId IdType="pubmed">29980595</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J. H., Frigault M. J., Serling-Boyd N. J., Fernandes A. D., Harvey L., Foulkes A. S., et al. (2020). Efficacy of tocilizumab in patients hospitalized with Covid-19. N. Engl. J. Med. 383 2333&#x2013;2344. 10.1056/NEJMoa2028836</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2028836</ArticleId><ArticleId IdType="pmc">PMC7646626</ArticleId><ArticleId IdType="pubmed">33085857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. (2021). Attributes and predictors of long COVID. Nat. Med. 27 626&#x2013;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I., et al. (2020). Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation 142 342&#x2013;353. 10.1161/CIRCULATIONAHA.120.047971</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., et al. (2020). Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 22 911&#x2013;915. 10.1002/ejhf.1828</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraih E. A., Elshazli R. M., Hussein M. H., Elgaml A., Amin M., El-Mowafy M., et al. (2020). Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: a meta-regression and decision tree analysis. J. Med. Virol. 92 2473&#x2013;2488. 10.1002/jmv.26166</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26166</ArticleId><ArticleId IdType="pmc">PMC7307124</ArticleId><ArticleId IdType="pubmed">32530509</ArticleId></ArticleIdList></Reference><Reference><Citation>Unsworth R., Wallace S., Oliver N. S., Yeung S., Kshirsagar A., Naidu H., et al. (2020). New-Onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Dia Care 43 e170&#x2013;e171. 10.2337/dc20-1551</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1551</ArticleId><ArticleId IdType="pubmed">32816997</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Claggett B. L., Chatterjee N. A., Anand I. S., Sweitzer N. K., Fang J. C., et al. (2018). Sudden death in heart failure with preserved ejection fraction. JACC: Heart Fail. 6 653&#x2013;661. 10.1016/j.jchf.2018.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2018.02.014</ArticleId><ArticleId IdType="pubmed">29501806</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani S. S., Alonso A., Aparicio H. J., Benjamin E. J., Bittencourt M. S., Callaway C. W., et al. (2021). Heart disease and stroke statistics&#x2014;2021 update: a report from the American Heart Association. Circulation 143 e254&#x2013;e743. 10.1161/CIR.0000000000000950</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000950</ArticleId><ArticleId IdType="pubmed">33501848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Wu C., Zhang Q., Wu F., Yu B., Lv J., et al. (2020). Epidemiological and Clinical Features of Corona Virus Disease 2019 (COVID-19) in Changsha, China (3/1/2020). 10.2139/ssrn.3548770</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3548770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Chen Z., Lin Y., Lin L., Lin Q., Fang S., et al. (2020). Clinical characteristics of COVID-19 in Fujian Province: a multicenter retrospective study. Res. Sq. 1&#x2013;20. [preprint]. 10.21203/rs.3.rs-21268/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-21268/v1</ArticleId><ArticleId IdType="pmc">PMC7660474</ArticleId><ArticleId IdType="pubmed">33180862</ArticleId></ArticleIdList></Reference><Reference><Citation>worldmeters (2021). worldometers: Coronavirus. Available online at: https://www.worldometers.info/coronavirus</Citation></Reference><Reference><Citation>Wu D., Wu T., Liu Q., Yang Z. (2020). The SARS-CoV-2 outbreak: what we know. Int. J. Infect. Dis. 94 44&#x2013;48. 10.1016/j.ijid.2020.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7102543</ArticleId><ArticleId IdType="pubmed">32171952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 323:1239. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T.-Y., Redwood S., Prendergast B., Chen M. (2020). Coronaviruses and the cardiovascular system: acute and long-term implications. Eur. Heart J. 41 1798&#x2013;1800. 10.1093/eurheartj/ehaa231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale I. T., Lucas C., Wong P., Klein J., Castro T. B. R., Silva J., et al. (2020). Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584 463&#x2013;469. 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J. K., Feng Y., Yuan M. Y., Yuan S. Y., Fu H. J., Wu B. Y., et al. (2006). Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diab. Med. 23 623&#x2013;628. 10.1111/j.1464-5491.2006.01861.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2006.01861.x</ArticleId><ArticleId IdType="pubmed">16759303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.-K., Lin S.-S., Ji X.-J., Guo L.-M. (2010). Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diab. 47 193&#x2013;199. 10.1007/s00592-009-0109-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-009-0109-4</ArticleId><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan B., An Y.-W., Chen Y.-X., Yang J., Wang J.-C., Li W.-X., et al. (2020). Epidemiological Characteristics of 417 patients infected with COVID-19 and 368 discharged cases among them in Shenzhen City, China. Res. Sq. 1&#x2013;10. [preprint]. 10.21203/rs.3.rs-19554/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-19554/v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Jia H., Wang F., Sun X., Yang D., Xu M., et al. (2020). Clinical course and characteristics of Corona Virus Disease 2019 in Xiaoshan, Hangzhou: a retrospective study. Res. Sq. 1&#x2013;13. [preprint]. 10.21203/rs.3.rs-22080/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-22080/v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z., Yu H., Chen H., Qi W., Chen L., Chen G., et al. (2020). Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Crit. Care 24:525. 10.1186/s13054-020-03255-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03255-0</ArticleId><ArticleId IdType="pmc">PMC7450961</ArticleId><ArticleId IdType="pubmed">32854750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395 1054&#x2013;1062. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>